Increasing COVID-19 Trials is Offering an Opportunity for Global Monoclonal Antibodies Market
Published: Nov 2020
The global monoclonal antibodies market is estimated to grow at a CAGR of 8.6% during the forecast period. An increasing number of trials for monoclonal antibodies for COVID-19 patients. For instance, in October 2020, Celltrion Group declared the introduction of its Phase III clinical trial investigating CT-P59. It is an anti-COVID-19 monoclonal antibody therapy candidate.
Rising Prevalence and Spending on Cancer will Escalate the US Peptide Therapeutics Market
Published: Nov 2020
The US peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. The burden of cancer is growing at an alarming pace across the country. According to the Centers for Disease Control and Prevention (CDC), by end of 2020, the number of new cancer cases is expected increase from around 24% in men to more than one million cases every year in the US, and by about 21% in women to more than 900,000 cases per year in the country.
Technological Advancement in UK Pharma Industry will Escalate the UK Peptide Therapeutics Market
Published: Nov 2020
The UK peptide therapeutics market will see a considerable growth of 3.7% during the forecast period. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the acceptance of peptide therapeutics in the UK for the treatment of various health conditions, such as CVD, cancer, and others.
Extensive R&D Inpeptide for Novel Drugs will Escalate the North American Peptide Therapeutics Market
Published: Nov 2020
The North American peptide therapeutics market will see a considerable growth of 5.1% during the forecast period. The region has a significant presence of peptide therapeutics manufacturers, with extensive R&D in the peptide therapeutics market. The Peptide Therapeutics Foundation, a not-for-profit 501C (3) was also established in 2008 in the region with the intention to promote R&D of peptide therapeutics.
Rise in Peptide Synthesis Services in India is Escalating Indian Peptide Therapeutics Market
Published: Nov 2020
Indian peptide therapeutics market will see a considerable growth of 7.6% during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs.
Rising Prevalence of Diabetes and Osteoarthritis is Escalating the Germany Peptide Therapeutics Market
Published: Nov 2020
The German peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. As per the report published by the German Diabetes Center (DDZ), in 2019 more than 7.2% of the population in Germany suffered from diabetes, most of them suffering from Type 2 diabetes. The report estimates that the number of individuals with diabetes will increase significantly in the next two decades.
Substantial Prevalence of Chronic Diseases will Escalate the European Peptide Therapeutics Market
Published: Nov 2020
The European peptide therapeutics market will see a considerable growth of 4.3% during the forecast period. The region has a significant presence of peptide therapeutics industry players, with extensive R&D in the market. With the increase in the number of cases of cancer in the region, the demand for proper treatment and availability of drugs is expected to rise; thereby, augmenting the growth of peptide therapeutics for cancer treatment.
Significant Presence of Healthcare CROs in Chinais Escalating China Peptide Therapeutics Market
Published: Nov 2020
China's peptide therapeutics market will see a considerable growth of 6.8% during the forecast period. Since the last decade, China has emerged as a globally preferred destination for the outsourcing of drug research. The robust growth of China’s Contract Research (CRO) industry is encouraging the transition of outsourcing services at a large scale, thereby contributing to drug innovation.
Research and Events for Peptides will Escalate the Asia-Pacific Peptide Therapeutics Market
Published: Nov 2020
The Asia-Pacific peptide therapeutics market will see a considerable growth of 6.7% during the forecast period. Asia-Pacific is one of the promising regions in the field of peptides. The frequent collaboration of various global and domestic companies through workshops and seminars is also expected to present a new growth opportunity for the Asia-Pacific peptide therapeutics market.
Easy Availability of the Medical Devices in the Region to Brace the European Injection Pen Market Growth
Published: Nov 2020
The European injection pen market is anticipated to grow at a CAGR of 7.4% over the forecast period (2020-2026). The key factors that drive the growth of the market in the region include easy availability of these devices in the region owing to the presence of key players such as Sanofi SA, Novo Nordisk AS, F. Hoffmann-La Roche Ltd. among many others which are pioneers in innovation, design, and manufacture of the injection pen.